go to contents go to side menu go to main menu

main menu area

main menu area

Innovative University Changing the World through Convergence

Embed to SNS

Translational Responsive Medicine Center

Translational research: Stimulation to Response, Diagnosis to Therapy, Basic to Clinical, Lab to Market

The Translational Responsive Medicine Center is leading a future biomedical engineering field through the development of convergence biomedical engineering technologies targeting precise diagnostics and personalized therapeutics for intractable diseases based on nanobiotechnology, tissue engineering, cell engineering, and high-throughput-screening technology.

Research Goals
  • Development and commercialization of precise biomedical technology for diagnosis and treatment of intractable diseases
  • Realization of start-up in the fields of personalized therapeutic drugs and diagnosis
  • Synergy maximization with Daegu & Gyeongbuk medical cluster and contribution to companies in local community
Major Research Fields & Contents

Biochip as a personalized disease model

  • BioMEMS (biomedical microelectromechanical systems)
  • 3D bioprinting technology
  • Super-precise tissue engineering

Precise biomedical stimulation technology

  • Mechanotransduction based on physical stimulation
  • High-throughput-screening platform for evaluation of drugs and physical stimulations

Disease diagnosis with liquid biopsy and immunotherapeutic approach

  • Lab-on-a-disc technology to separate precisely various cells and exosome from liquid biopsy
  • Engineered immune cells for therapeutic approach
Director
    Guidance for Director,E-mail,Tel
    Director Minseok S. Kim
    E-mail kms@dgist.ac.kr
    Tel 053-785-1740